# Equity Research

This folder contains independent equity research focused on fundamental business analysis, industry structure, and long-term value creation. The work emphasizes qualitative reasoning, financial context, and evolving competitive dynamics rather than short-term price movements.

## Included Research

### GLP-1 Therapies: Competitive Dynamics Between Eli Lilly and Novo Nordisk
An analysis of the obesity and diabetes drug market, examining the divergent performance of Eli Lilly and Novo Nordisk amid shifting market share, pricing pressure, insurance coverage expansion, and regulatory developments. The note reflects an updated view incorporating recent product and policy developments.

ðŸ“„ Research Note:  
[`glp1_competitive_dynamics_lly_vs_nvo.md`](glp1_competitive_dynamics_lly_vs_nvo.md)

## Approach
- Bottom-up fundamental analysis
- Industry and competitive landscape assessment
- Integration of policy, regulatory, and reimbursement considerations
- Willingness to update views as new information emerges

## Disclaimer
All research reflects personal analysis and opinion and is provided for educational purposes only. Nothing herein constitutes investment advice.
